Shares of Stericycle SRCL were unchanged after the company reported Q2 results.
Quarterly Results
Earnings per share rose 45.65% year over year to $0.67, which missed the estimate of $0.69.
Revenue of $672,700,000 up by 12.45% year over year, which beat the estimate of $669,430,000.
Looking Ahead
Stericycle hasn't issued any earnings guidance for the time being.
Revenue guidance hasn't been issued by the company for now.
How To Listen To The Conference Call
Date: Aug 06, 2021
Time: 11:00 AM
ET Webcast URL: https://78449.choruscall.com/dataconf/productusers/srcl/mediaframe/45239/indexr.html
Technicals
Company's 52-week high was at $79.97
Company's 52-week low was at $59.51
Price action over last quarter: down 7.68%
Company Overview
Stericycle is the largest provider of medical waste disposal and data destruction ( primarily paper shredding) services in the United States. Its next closest national competitor in the medical waste disposal space is Sharps Compliance, which generated $51 million of sales in 2020 (about 3% of Stericycle's global regulated waste and compliance revenue). Stericycle's data destruction business (Shred-It) is about twice the size of its closest competitor (Iron Mountain's information destruction segment). Stericycle has a global presence, with about 20% of its revenue earned outside North America. Globally, the company has 188 transfer sites, 232 processing facilities, and 7,800 trucks.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.